(4-aminophenyl)(2,3-dihydro-1,4-benzodioxin-6-yl)methanone hydrochloride, 95.0%, 500mg

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-1H-imidazole, 98%, 1g

tert-Butyl 4-methyl-3-oxopiperazine-1-carboxylate, 95.0%, 5g

1-Bromo-2,4-difluoro-5-(trifluoromethyl)benzene, 98%, 1g

Símbolo de advertencia según ISO 7010 Etiqueta individual, Rayo láser, Longitud lateral 200 mm, 1 pieza

1-(TETRAHYDROFURAN-3-YL)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE, 95.0%, 5g

2-Fluoro-5-(4-(trifluoromethoxy)phenyl)pyridine, 97%, 1g

2-(2-Methoxyphenyl)acetyl chloride, 95.0%, 2g

N-(2,6-Dimethylphenyl)piperidine-2-carboxamide, 95.0%, 10g

2-Butanol, mínimo 98,5%, para síntesis, 25 l, envase de plástico.

5,8-DIAZA-SPIRO[3.5]NONANE-5-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 5g

Methyl 2,4-dichloro-5-fluorobenzoate, 98%, 25g

5-Bromo-2-methoxynicotinonitrile, 95.0%, 1g